Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RUFINAMIDE vs SACCHAROMYCES CEREVISIAE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RUFINAMIDE vs SACCHAROMYCES CEREVISIAE: Safety Overview

Metric RUFINAMIDE SACCHAROMYCES CEREVISIAE
Total FAERS Reports 871 284
Deaths Reported 27 85
Death Rate 3.1% 29.9%
Hospitalizations 229 159
Average Patient Age 16.9 yrs 62.1 yrs
% Female Patients 50.2% 59.4%
FDA Approval Date Apr 15, 2025 N/A
Manufacturer Aurobindo Pharma Limited DNA Labs, Inc.
Route ORAL SUBLINGUAL
Marketing Status Discontinued N/A